Latest filing published 27 Apr 2015 for Esperion Therapeutics, Inc., €15.1M.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +42.9%Entry US$8.40 · Close at T+365 US$12.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Aisling Capital II LP: trading record in brief
Aisling Capital II LP discloses dealings in 3 companies, chiefly Esperion Therapeutics, Inc., Adma Biologics, Inc. and Cempra, Inc. Over a trading history stretching from 7 February 2012 to 24 April 2015, the count stands at 7 filings.
Both buying and selling appear: 3 purchases worth €10.6M, against 3 sales worth €21.8M. On balance, insiders were net sellers of €11.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2015 to date brings no purchases and 3 sales.
The median purchase comes to €2.6M.
The record was last updated on 27 April 2015 with an open-market sale (€15.1M) in Esperion Therapeutics, Inc. The most recent open-market purchase was published on 23 October 2013, 4,765 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Aisling Capital II LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$109.10Common StockSEC:0000950142-15-000894:0
- 5,743 shares@ US$108.00Common StockSEC:0000950142-15-000894:1
- 61,726 shares@ US$106.10Common StockSEC:0000950142-15-000894:2
- 411,765 shares@ US$8.50Common StockSEC:0000950142-13-002123:0Canonical exit: 20 Jan 2014 (T+90)
- 1,816,475 sharesCommon StockSEC:0001179110-13-011142:0
- 238,119 shares@ US$14.00Common StockSEC:0001179110-13-011142:1Canonical exit: 29 Sept 2013 (T+90)
- 1,213,663 shares@ US$6.00Common StockSEC:0000950142-12-000248:0Canonical exit: 7 May 2012 (T+90)
7 of 7 declarations
